Temporal Lobe Epilepsy Clinical Trials
2 recruiting trials for Temporal Lobe Epilepsy. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Temporal Lobe Epilepsy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of California, Davis (1), Assistance Publique Hopitaux De Marseille (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Virtual Tour Recognition Memory Task (behavioral, 1 trial), followed by Intracranial EEG Recording with Research Electrodes (Aim III only), MRI Neuroimaging and Neuropsychological Assessment (Aim I).
Track Temporal Lobe Epilepsy trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Spatial Scene Recognition Memory in Epilepsy Surgery
This study investigates the anatomical and physiological basis of spatial scene recognition memory in patients with temporal lobe epilepsy and temporal lobe lesions. Standard...
Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy
Out of 30,000 new cases per year in France, 30% of epileptic patients are drug-resistant. Neurosurgery, which consists in resecting the epileptogenic zone, is the only chance of...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Temporal Lobe Epilepsy, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Temporal Lobe Epilepsy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Temporal Lobe Epilepsy, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.